← All stories
Markets
H.I.G. Is Said to Consider Sale of $1 Billion Drugmaker Rising Pharma
H.I.G. Capital is exploring options for its controlling stake in US-based Rising Pharmaceuticals, including a possible sale, according to people familiar with the matter.
Covered by 1 outlet
All coverage · 1 article